VRAX (Virax Biolabs Group) Other Stockholders Equity : $-0.00 Mil (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Virax Biolabs Group Other Stockholders Equity?

Virax Biolabs Group's Other Stockholders Equity for the quarter that ended in Sep. 2024 was $-0.00 Mil.

Virax Biolabs Group's quarterly Other Stockholders Equity declined from Sep. 2023 ($0.00 Mil) to Mar. 2024 ($-0.00 Mil) and declined from Mar. 2024 ($-0.00 Mil) to Sep. 2024 ($-0.00 Mil).

Virax Biolabs Group's annual Other Stockholders Equity declined from Mar. 2022 ($-0.00 Mil) to Mar. 2023 ($-0.00 Mil) but then increased from Mar. 2023 ($-0.00 Mil) to Mar. 2024 ($-0.00 Mil).

Virax Biolabs Group Other Stockholders Equity Historical Data

The historical data trend for Virax Biolabs Group's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virax Biolabs Group Other Stockholders Equity Chart

Virax Biolabs Group Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Other Stockholders Equity

-0.05

Virax Biolabs Group Semi-Annual Data
	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Other Stockholders Equity	Get a 7-Day Free Trial					-	-	-	-	-

Virax Biolabs Group Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Virax Biolabs Group Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Virax Biolabs Group's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Virax Biolabs Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Virax Biolabs Group Ltd (NAS:VRAX) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bo’Ness Road Newhouse, BioCity Glasgow, London, GBR, ML1 5UH

Website

https://www.viraxbiolabs.com

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.